Artikel, Notizen und Markierungen werden geladen... Bitte um etwas Geduld.
Medical Devices Ordinance (MedDO)
English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.
of 1 July 2020 (Status as of 26 May 2021)
Art. 63
1 For class III devices and for implantable devices, other than custom-made or investigational devices, the manufacturer must draw up a summary of safety and clinical performance.
2 The summary of safety and clinical performance shall be written in a way that is clear to the intended user and, if relevant, to the patient.
3 The minimum content of the summary is governed by Article 32, Paragraph 32 EU-MDR75.
4 The draft summary of safety and clinical performance must be submitted to the designated body involved in the conformity assessment pursuant to Article 24 for validation by that body.
5 The manufacturer will publish the summary after it has been validated.76
6 The manufacturer must mention on the label or instructions for use where the summary is available.
75 See the footnote to Art. 4 para. 1 let. f.
76 Amended by No I of the O of 19 May 2021, in force since 26 May 2021 (AS 2021 281).